Business

Bionik Laboratories to Present at the 18th Annual BIO CEO & Investor Conference on February 8, 2016

Bionik Laboratories to Present at the 18th Annual BIO CEO & Investor Conference on February 8, 2016.

articleBionik Laboratories Corp.February 2, 20164/company/bionik-laboratories-corp/news/bionik-laboratories-to-present-at-the-18th-annual-bio-ceo-and-investor-conference-on-february-8-2016
Bionik Laboratories to Present at the 18th Annual BIO CEO & Investor Conference on February 8, 2016

About this update from Bionik Laboratories Corp.

[{"type":"text","content":"\n\n\n\nBionik Laboratories to Present at the 18th Annual BIO CEO & Investor Conference on February 8, 2016\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nBionik Laboratories to Present at the 18th Annual BIO CEO & Investor Conference on February 8, 2016\n- Presentation with live webcast on Monday, February 8 at 1:30 p.m. EST -\nPR Newswire\nTORONTO, Feb. 2, 2016\n\n\n\nTORONTO, Feb. 2, 2016 /PRNewswire/ -- Bionik Laboratories Corp. (OTCQX: BNKL), a pioneering medical device and robotics company with a focus in developing technologies and solutions for individuals with neurological disorders (\"Bionik\" or the \"Company\"), announced today that Peter Bloch, Chief Executive Officer and Chairman of the Board, will present at the 18th Annual BIO CEO & Investor Conference on Monday, February 8, 2016 at 1:30 p.m. EST in New York, NY.\n\n\nMr. Bloch will present a corporate overview and provide an update on the progress of its primary product, ARKE™, a robotic lower-body exoskeleton device designed to allow paraplegics as well as other wheelchair users the ability to rehabilitate through walking and other motion. Bionik expects to report key verification and clinical data on ARKE from testing in Canadian rehabilitation centers in mid-2016. The Company's growth strategy focused on acquiring, licensing and partnering synergistic products and technologies to enhance its internal product pipeline will also be discussed.\n\nA live webcast of the presentation will be available on Bionik's IR Calendar in the Investor Relations section of the Company's website (www.bioniklabs.com). The webcast replay will be available approximately two hours after the presentation ends and will be archived for 30 days.\n\nAbout BIO BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental b...

More updates from Bionik Laboratories Corp.